0001179110-16-022254.txt : 20160328
0001179110-16-022254.hdr.sgml : 20160328
20160328171954
ACCESSION NUMBER: 0001179110-16-022254
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150429
FILED AS OF DATE: 20160328
DATE AS OF CHANGE: 20160328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 38 SIDNEY STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 38 SIDNEY STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lengauer Christoph
CENTRAL INDEX KEY: 0001638469
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 161533004
MAIL ADDRESS:
STREET 1: BLUEPRINT MEDICINES CORP.
STREET 2: 215 FIRST STREET, SUITE 340/350
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
3/A
1
edgar.xml
FORM 3/A -
X0206
3/A
2015-04-29
2015-04-30
0
0001597264
Blueprint Medicines Corp
BPMC
0001638469
Lengauer Christoph
C/O BLUEPRINT MEDICINES CORPORATION
38 SIDNEY STREET, SUITE 200
CAMBRIDGE
MA
02139
0
1
0
0
Chief Scientific Officer
Common Stock
188332
D
Stock Option (Right to Buy)
1.485
2023-11-03
Common Stock
35227
D
Stock Option (Right to Buy)
1.87
2024-08-14
Common Stock
24848
D
Stock Option (Right to Buy)
8.800
2025-02-10
Common Stock
53408
D
Table II, column 3 of the Form 3 filed on April 30, 2015 (the "Original Form 3") inadvertently included an aggregate of 24,696 shares underlying stock options, which the Reporting Person had previously exercised. These shares were also inadvertently omitted from Table I, column 2 of the Original Form 3. The Reporting Person previously filed an amendment to the Original Form 3 on May 1, 2015 reporting the beneficial ownership of an aggregate of 188,332 shares of common stock in Table I, including the 24,696 shares omitted from Table I, column 2 of the Original Form 3. This amendment is being filed to reduce the aggregate number of shares underlying derivative securities reported in Table II, column 3 of the Original Form 3 by 24,696 shares. These shares were also inadvertently included in the aggregate number of shares underlying derivative securities reported in Table II, column 9 of a Form 4 filed by the Reporting Person on February 5, 2016.
This option vests in 48 equal monthly installments beginning on November 1, 2013.
This option vests in 48 equal monthly installments beginning on August 18, 2014.
This option vests in 48 equal monthly installments beginning on February 10, 2015.
/s/ Christine Bellon, Attorney-in-Fact
2016-03-28